{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T15:17:26Z","timestamp":1771255046310,"version":"3.50.1"},"reference-count":21,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reports"],"abstract":"<jats:p>Background and Clinical significance: This case describes a patient with a complex medical history who develops an active Mycobacterium tuberculosis (MTB) infection. The complex multidrug regimen has led to significant drug\u2013drug interactions (DDIs) and adverse effects. This case highlights an urgent need for standardized guidelines on dose adjustment and therapeutic monitoring for opioid substitution therapy (OST) and antiretroviral therapy (ART) during MTB treatment to prevent adverse health outcomes and ensure clinical success. Case Presentation: A 43-year-old man with medical history including human immunodeficiency virus (HIV), chronic hepatitis C virus (HCV), psychotic disorder, and opioid dependence maintained on buprenorphine (24 mg\/day) presented with acute psychosis and respiratory symptoms. During hospitalization, he was diagnosed with MTB infection and was started on an empirical rifampicin-based anti-MTB regimen. His clinical course was complicated by reduced buprenorphine efficacy caused by rifampicin, which precipitated opioid withdrawal symptoms. Conclusions: The successful clinical stabilization with resolution of withdrawal syndrome, reduced agitation, and normalization of vital signs, including heart rate and blood pressure of this patient, was achieved through targeted management of pervasive DDIs. A strategic ART switch and careful buprenorphine dose titration during rifampicin therapy was the key factor. This case highlights that co-managing HIV, MTB, and opioid use disorder presents a significant challenge where unaddressed DDIs directly threaten treatment efficacy, a patient\u2019s safety, and adherence, and may result in increased toxicity. The case underscores the critical need for proactive DDI assessment, interdisciplinary collaboration, and guideline development for medication optimization in people living with HIV receiving OST.<\/jats:p>","DOI":"10.3390\/reports9010064","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T14:09:54Z","timestamp":1771250994000},"page":"64","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Drug Interactions Are Crucial in the Care of Patients on Opioid Substitutional Therapy\u2014A Case Report"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1098-3811","authenticated-orcid":false,"given":"Sai Keertana","family":"Devarapalli","sequence":"first","affiliation":[{"name":"English Division of the Faculty of Medicine, Medical University of Warsaw, \u017bwirki i Wigury 61, 02-091 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8144-0205","authenticated-orcid":false,"given":"Anna","family":"Furman-D\u0142uba\u0142a","sequence":"additional","affiliation":[{"name":"Hospital for Infectious Diseases in Warsaw, Wolska 37, 01-201 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Bednarska","sequence":"additional","affiliation":[{"name":"Hospital for Infectious Diseases in Warsaw, Wolska 37, 01-201 Warsaw, Poland"},{"name":"Department of Adults\u2019 Infectious Diseases, Medical University of Warsaw, \u017bwirki i Wigury 61, 02-091 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1166-4462","authenticated-orcid":false,"given":"Justyna Dominika","family":"Kowalska","sequence":"additional","affiliation":[{"name":"Hospital for Infectious Diseases in Warsaw, Wolska 37, 01-201 Warsaw, Poland"},{"name":"Infectious Disease Observational Research Unit, Medical University of Warsaw, \u017bwirki i Wigury 61, 02-091 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/S0140-6736(19)32229-9","article-title":"Global Patterns of Opioid Use and Dependence: Harms to Populations, Interventions, and Future Action","volume":"394","author":"Degenhardt","year":"2019","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1445-5994.2012.02714.x","article-title":"Management of Opioid Substitution Therapy during Medical Intervention","volume":"42","author":"Murnion","year":"2012","journal-title":"Intern. Med. J."},{"key":"ref_3","unstructured":"(2026, January 13). EACS Guidelines 2025. Available online: https:\/\/eacs.sanfordguide.com\/."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/02791072.2003.10400007","article-title":"The Clinical Opiate Withdrawal Scale (COWS)","volume":"35","author":"Wesson","year":"2003","journal-title":"J. Psychoact. Drugs"},{"key":"ref_5","unstructured":"World Health Organization (2021). Consolidated Guidelines on HIV Prevention, Testing, Treatment, Service Delivery and Monitoring: Recommendations for a Public Health Approach."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/10550887.2013.824333","article-title":"Comparison of QTc Interval Prolongation for Patients in Methadone Versus Buprenorphine Maintenance Treatment: A 5-Year Follow-Up","volume":"32","author":"Fareed","year":"2013","journal-title":"J. Addict. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/ADM.0000000000000176","article-title":"Presence or Absence of QTc Prolongation in Buprenorphine-Naloxone Among Youth with Opioid Dependence","volume":"10","author":"Poole","year":"2016","journal-title":"J. Addict. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.hrthm.2023.10.027","article-title":"Incidences, Risk Factors, and Clinical Correlates of Severe QT Prolongation after the Use of Quetiapine or Haloperidol","volume":"21","author":"Wang","year":"2024","journal-title":"Heart Rhythm"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0165-1781(03)00107-0","article-title":"Effects of Intramuscular Olanzapine vs. Haloperidol and Placebo on QTc Intervals in Acutely Agitated Patients","volume":"119","author":"Lindborg","year":"2003","journal-title":"Psychiatry Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2165\/00003088-200342090-00003","article-title":"Pharmacokinetic Interactions with Rifampicin","volume":"42","author":"Niemi","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/cid\/ciu046","article-title":"Lower Pill Burden and Once-Daily Antiretroviral Treatment Regimens for HIV Infection: A Meta-Analysis of Randomized Controlled Trials","volume":"58","author":"Nachega","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/23744235.2019.1565415","article-title":"People Who Inject Drugs Remain Hard-to-Reach Population across All HIV Continuum Stages in Central, Eastern and South Eastern Europe\u2014Data from Euro-Guidelines in Central and Eastern Europe Network","volume":"51","author":"Balayan","year":"2019","journal-title":"Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0024-3205(97)00160-4","article-title":"Involvement of Cytochrome P450 3A4 in N-Dealkylation of Buprenorphine in Human Liver Microsomes","volume":"60","author":"Iribarne","year":"1997","journal-title":"Life Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1124\/dmd.105.003681","article-title":"In vitro metabolism study of buprenorphine: Evidence for new metabolic pathways","volume":"33","author":"Picard","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e00271","DOI":"10.1002\/prp2.271","article-title":"Rifampicin Decreases Exposure to Sublingual Buprenorphine in Healthy Subjects","volume":"4","author":"Hagelberg","year":"2016","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.drugalcdep.2011.04.013","article-title":"Rifampin, but Not Rifabutin, May Produce Opiate Withdrawal in Buprenorphine-Maintained Patients","volume":"118","author":"Moody","year":"2011","journal-title":"Drug Alcohol. Depend."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.01043-21","article-title":"Model-Based Comparative Analysis of Rifampicin and Rifabutin Drug-Drug Interaction Profile","volume":"65","author":"Tuloup","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_18","unstructured":"Centers for Disease Control and Prevention (CDC) (2000). Updated Guidelines for the Use of Rifabutin or Rifampin for the Treatment and Prevention of Tuberculosis among HIV-Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors. MMWR Morb. Mortal. Wkly Rep., 49, 185\u2013189."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e25333","DOI":"10.1002\/jia2.25333","article-title":"Global Access of Rifabutin for the Treatment of Tuberculosis\u2014Why Should We Prioritize This?","volume":"22","author":"Rockwood","year":"2019","journal-title":"J. Int. AIDS Soc."},{"key":"ref_20","unstructured":"(2026, January 13). Liverpool HIV Interactions. Available online: https:\/\/hiv-druginteractions.org\/checker."},{"key":"ref_21","unstructured":"(2026, January 13). Drugs.com. Available online: https:\/\/www.drugs.com."}],"container-title":["Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2571-841X\/9\/1\/64\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T14:36:24Z","timestamp":1771252584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2571-841X\/9\/1\/64"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,14]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["reports9010064"],"URL":"https:\/\/doi.org\/10.3390\/reports9010064","relation":{},"ISSN":["2571-841X"],"issn-type":[{"value":"2571-841X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,14]]}}}